StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Allylamine → 2-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine

HRID 597904
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 597904
BrC1C(CCOS(C)(=O)=O)=NC(OC)=CC=1.C(N)C=C.CCN(CC)CC.C(OC(C(F)(F)F)=O)(C(F)(F)F)=O.C([O-])(O)=O.[Na+].[CH2:46]([N:49]([CH2:56][CH2:57][C:58]1[C:63](Br)=[CH:62][CH:61]=[C:60]([O:65][CH3:66])[N:59]=1)[C:50](=[O:55])[C:51]([F:54])([F:53])[F:52])[CH:47]=[CH2:48].CC([O-])=O.[Na+]>C(#N)C.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.CC(N(C)C)=O.CCOC(C)=O>[CH3:66][O:65][C:60]1[CH:61]=[CH:62][C:63]2[C:47](=[CH2:48])[CH2:46][N:49]([C:50](=[O:55])[C:51]([F:54])([F:53])[F:52])[CH2:56][CH2:57][C:58]=2[N:59]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

12

Edukt 7

HCID 7853AllylamineHCID 8471TriethylamineHCID 9845Trifluoroacetic anhydrideHCID 516892Sodium BicarbonateHCID 517045Sodium AcetateHCID 873326163-Bromo-2-(2-methanesulfonyloxyethyl)-6-methoxypyridine
HCID 87332658
n-Allyl-n-[2-(3-bromo-6-methoxypyridin-2-yl)ethyl]-2,2,2-trifluoroacetamide

Produkt 1

HCID 236541062-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepineAusbeute 62 %

Reagenzien, Katalysatoren, Lösungsmittel 4

HCID 178418476HCID 178418476, VerbindungKatalysatorHCID 6342AcetonitrileLösungsmittelHCID 8857Ethyl AcetateLösungsmittelHCID 31374DimethylacetamideLösungsmittel

Versuchsvorschrift

2-Methoxy-6-methylpyridine was diluted with THF to a total volume of 20 ml. It was cooled to −78° C. and treated with nBuLi (2.5 M in hexane, 4.8 ml, 11.9 mmol). After 15 min at −78° C., HMPA (2.1 ml, 11.92 mmol) was added and the mixture was allowed to warm to 0° C. Paraformaldehyde (1.38 g, 45.85 mmol) was added and the mixture was allowed to gradually warm to ambient temperature. The reaction was quenched with NH4Cl and extracted with EtOAc. The organic layer was dried, concentrated in vacuo and purified by column chromatography to render 0.45 g (32%) of 2-(6-methoxypyridin-2-yl)ethanol. 1H-NMR (CDCl3) δ 7.49 (dd, 1H), 6.72 (d, 1H), 6.60 (d, 1H), 4.46 (br s, 1H), 3.99 (t, 2H) 3.88 (s, 3H), 2.92 (t, 2H) ppm. Br2 (1.67 ml, 32.6 mmol) was added dropwise to a mixture of 2-(6-methoxypyridin-2-yl)ethanol (5.00 g, 32.6 mmol), Na2HPO4 buffer (1.0 1) and MeOH (110 ml). After stirring for 12 h at ambient temperature, the reaction mixture was parted between EtOAc and NaHCO3. The organic phase was washed with brine, dried over Na2SO4 and concentrated in vacuo. Chromatographic purification rendered 7.00 g (93%) of 2-(3-bromo-6-methoxypyridin-2-yl)ethanol. 1H-NMR (CDCl3) δ 7.69 (d, 1H), 6.56 (d, 1H), 4.06 (t, 2H), 3.91 (s, 3H), 3.08 (t, 2H) ppm. To a solution of 2-(3-bromo-6-methoxypyridin-2-yl)ethanol (23.4 g, 0.10 mol) in DCM (468 ml) were added Et3N (13.6 g, 0.131 mol) and MsCl (12.1 g, 0.106 mol) at 0-5° C. After 30 min, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted with DCM. The organic phase was successively washed with water and brine, and then dried over Na2SO4 and concentrated in vacuo to give 32.5 g (99%) of 3-bromo-2-(2-methanesulfonyloxyethyl)-6-methoxypyridine. H-NMR (CDCl3) δ 7.68 (d, 1H), 6.56 (d, 1H), 4.74 (t, 2H), 3.92 (s, 3H), 3.32 (t, 2H), 3.00 (s, 3H) ppm. A mixture of 3-bromo-2-(2-methanesulfonyloxyethyl)-6-methoxypyridine (31.3 g, 0.10 mol), allylamine (90.5 ml, 1.21 mol) in acetonitrile (156 ml) was stirred at room temperature for 2 d. The reaction mixture was concentrated in vacuo, diluted with ethyl acetate, washed with sat. aq. NaHCO3 and water, and then dried over Na2SO4. After concentration in vacuo, the crude product was dissolved in DCM (273 ml) and reacted with Et3N (25.9 ml, 0.186 mol) and TFAA (15.4 ml, 0.11 mol) for 10 min at 5-10° C. The reaction mixture was parted between EtOAc and NaHCO3 and the organic phase was washed with brine, dried over Na2SO4 and concentrated in vacuo. Chromatographic purification rendered 25.4 g (69%) of N-allyl-N-[2-(3-bromo-6-methoxypyridin-2-yl)ethyl]-2,2,2-trifluoroacetamide. 1H-NMR (CDCl3) δ 7.64 (d), 7.62 (d), 6.52 (d), 6.51 (d), 5.82 (dddd), 5.72 (dddd), 5.28-5.18 (m), 4.11 (m), 3.91 (d), 3.91 (s), 3.81 (m), 3.16 (t) ppm. A mixture of N-allyl-N-[2-(3-bromo-6-methoxypyridin-2-yl)ethyl]-2,2,2-trifluoroacetamide (5.20 g, 14.2 mmol), (PPh3)2PdCl2 (4.98 g, 7.08 mmol), NaOAc (3.49 g, 42.5 mmol) and DMA (100 ml) was stirred for 24 h at 130° C. Evaporation of solvent and chromatographic purification of the residue yielded 2.50 g (62%) of 2-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine. 1H-NMR (CDCl3) δ 7.51 (d, 1H), 6.61 (d, 1H), 5.39 (d, 1H), 5.30 (d, 1H), 4.43 (d, 2H), 3.94-3.87 (m, 5H), 3.20 (m, 2H) ppm. A mixture of 2-methoxy-5-methylene-7-(trifluoroacetyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine (100 mg, 349 μmol) and K2CO3 (110 mg) in MeOH (6 ml) was heated for 1 h at 60° C. The reaction mixture was concentrated in vacuo and chromatographic purification rendered 39 mg (59%) of 2-methoxy-5-methylene-6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine. 1H-NMR (CDCl3) δ 7.47 (d, 1H), 6.58 (d, 1H), 5.28 (d, 1H), 5.21 (d, 1H), 3.93 (s, 3H), 3.64 (d, 2H), 3.19 (m, 2H), 3.10 (m, 2H) ppm.

Aufarbeitung

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. additiondiluted with ethyl acetate
  3. washwashed with sat. aq. NaHCO3 and water
  4. dry with materialdried over Na2SO4
  5. concentrationAfter concentration in vacuo
  6. dissolutionthe crude product was dissolved in DCM (273 ml)
  7. washthe organic phase was washed with brine
  8. dry with materialdried over Na2SO4
  9. concentrationconcentrated in vacuo
  10. customChromatographic purification
  11. stirringwas stirred for 24 h at 130° C
  12. customEvaporation of solvent and chromatographic purification of the residue

Quellen und Nachweise

ORD-Eintrag
ord-8e1909369926426997f97ac9fb42ae0d
Quelldatensatz
uspto-grants-2011_03
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07897595B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion